|
|
Kenneth R. Hallows, Viswanathan Raghuram, Bruce E. Kemp, Lee A. Witters, J. Kevin Foskett
J Clin Invest. 2000;
105(12):1711
doi:10.1172/JCI9622
Abstract |
Full text
| PDF

T
he cystic fibrosis transmembrane conductance regulator (CFTR) is an ATP-gated Cl– channel that regulates other epithelial transport proteins by uncharacterized mechanisms. We employed a yeast two-hybrid screen using the COOH-terminal 70 residues of CFTR to identify proteins that might be involved in such interactions. The α1 (catalytic) subunit of AMP-activated protein kinase (AMPK) was identified as a dominant and novel interacting protein. The interaction is mediated by residues 1420–1457 in CFTR and by the COOH-terminal regulatory domain of α1-AMPK. Mutations of two protein trafficking motifs within the 38–amino acid region in CFTR each disrupted the interaction. GST-fusion protein pull-down assays in vitro and in transfected cells confirmed the CFTR-α1-AMPK interaction and also identified α2-AMPK as an interactor with CFTR. AMPK is coexpressed in CFTR-expressing cell lines and shares an apical distribution with CFTR in rat nasal epithelium. AMPK phosphorylated full-length CFTR in vitro, and AMPK coexpression with CFTR in Xenopus oocytes inhibited cAMP-activated CFTR whole-cell Cl– conductance by approximately 35–50%. Because AMPK is a metabolic sensor in cells and responds to changes in cellular ATP, regulation of CFTR by AMPK may be important in inhibiting CFTR under conditions of metabolic stress, thereby linking transepithelial transport to cell metabolic state.
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal.
Not all publishers participate in CrossRef, so this information is not comprehensive.
Additionally, data may not reflect the most current citations to this article,
and the data may differ from citation information available from other sources
(for example, Google Scholar, Web of Science, and Scopus).
About CrossRef
| Title and authors |
Publication |
Year |
. |
Inhibition of the heterotetrameric K+channel KCNQ1/KCNE1 by the AMP-activated protein kinase
Ioana Alesutan, Michael Föller, Mentor Sopjani, Miribane Dërmaku-Sopjani, Christine Zelenak, Henning Fröhlich, Ana Velic, Scott Fraser, Bruce E. Kemp, Guiscard Seebohm, Harald Völkl, Florian Lang |
Molec Memb Biol |
2011 |
.
|
AMP-activated protein kinase connects cellular energy metabolism to KATP channel function
Hidetada Yoshida, Li Bao, Eirini Kefalogianni, Eylem Taskin, Uzoma Okorie, Miyoun Hong, Piyali Dhar-Chowdhury, Michiyo Kaneko, William A. Coetzee |
Mol Cell Cardiol |
2011 |
.
|
Activating AMP-activated protein kinase (AMPK) slows renal cystogenesis
V. Takiar, S. Nishio, P. Seo-Mayer, J. D. King, H. Li, L. Zhang, A. Karihaloo, K. R. Hallows, S. Somlo, M. J. Caplan |
Proc Natl Acad Sci U S A |
2011 |
.
|
In vivo stimulation of AMP-activated protein kinase enhanced tubuloglomerular feedback but reduced tubular sodium transport during high dietary NaCl intake
Dan Yang Huang, Huanhuan Gao, Krishna M. Boini, Hartmut Osswald, Bernd Nürnberg, Florian Lang |
Pfluegers Archiv |
2010 |
.
|
Involvement of F1296 and N1303 of CFTR in induced-fit conformational change in response to ATP binding at NBD2
A. Szollosi, P. Vergani, L. Csanady |
J Gen Physiol |
2010 |
.
|
AMPK controls epithelial Na+ channels through Nedd4-2 and causes an epithelial phenotype when mutated
Joana Almaça, Patthara Kongsuphol, Bernhard Hieke, Jiraporn Ousingsawat, Benoit Viollet, Rainer Schreiber, Margarida D. Amaral, Karl Kunzelmann |
Pfluegers Archiv |
2009 |
.
|
Assessment of the CFTR and ENaC association
Bakhrom K. Berdiev, Yawar J. Qadri, Dale J. Benos |
Mol Biosyst |
2009 |
.
|
Downregulation of AMP-activated protein kinase by Cidea-mediated ubiquitination and degradation in brown adipose tissue
Jingzong Qi, Jingyi Gong, Tongjin Zhao, Jie Zhao, Penny Lam, Jing Ye, John Zhong Li, Jiawei Wu, Hai-Meng Zhou, Peng Li |
EMBO J |
2008 |
.
|
Regulation of Cl− secretion by AMPK in vivo
Patthara Kongsuphol, Bernhard Hieke, Jiraporn Ousingsawat, Joana Almaca, Benoit Viollet, Rainer Schreiber, Karl Kunzelmann |
Pfluegers Archiv |
2008 |
.
|
Familial Wolff-Parkinson-White Syndrome: A Disease of Glycogen Storage or Ion Channel Dysfunction?
PETER E. LIGHT |
J Cardiovasc Electrophysiol |
2006 |
.
|
New insights into cystic fibrosis: molecular switches that regulate CFTR
William B. Guggino, Bruce A. Stanton |
Nature Reviews Molecular and Cell Biology |
2006 |
.
|
Cystic fibrosis enters the proteomics scene: New answers to old questions
Mario Ollero, Franck Brouillard, Aleksander Edelman |
PROTEOMICS |
2006 |
.
|
CFTR: More than just a chloride channel
Anil Mehta |
Pediat Pulmonol |
2005 |
.
|
Emerging role of AMP-activated protein kinase in coupling membrane transport to cellular metabolism
Kenneth R Hallows |
Curr Opin Nephrol Hypertens |
2005 |
.
|
Role of hypothalamic 5′-AMP-activated protein kinase in the regulation of food intake and energy homeostasis
Min Seon Kim, Ki Up Lee |
J Mol Med-JMM |
2005 |
.
|
5-Amino-imidazole carboxamide riboside acutely potentiates glucose-stimulated insulin secretion from mouse pancreatic islets by KATP channel-dependent and -independent pathways
Chang-Zheng Wang, Yong Wang, Anke Di, Mark A. Magnuson, Honggang Ye, Michael W. Roe, Deborah J. Nelson, Graeme I. Bell, Louis H. Philipson |
BIOPHYS BIOCHEM RES COMMUN |
2005 |
.
|
Michael Gollob, Martin Green, Anthony Tang, Robert Roberts |
Curr Opin Cardiol |
2002 |
.
|
The blooming of the French lilac
Lee A. Witters |
Journal Clinical Investigation |
2001 |
.
|
|
|
|